Manav Midha

Biography

Manav Midha is a researcher at the USC Schaeffer Center for Health Policy & Economics and an MD candidate at the Icahn School of Medicine at Mount Sinai.

Before medical school, he was a management consultant at McKinsey & Company, advising national nonprofit health systems, academic medical centers, and private equity investors on growth strategy, clinical operations, labor, external spend, patient experience, managed care negotiation, and revenue cycle management issues. He also led knowledge efforts to develop a novel approach to sizing and actioning on radiology fixed asset and labor productivity and built an analytical methodology for understanding forces impacting external innovation in global oncology.

Manav’s research lies at the intersection of biomedical science and economic analysis. His current work focuses on provider-side medical billing, private-sector incentives for long-term population health, perioperative site-of-care shifts in colectomy procedures, and neurosurgical decision-making regarding preoperative embolization of meningioma brain tumors.

Past projects have included studies on the cost-effectiveness of temozolomide chemotherapy for glioblastoma patients with unmethylated MGMT gene promoter regions, the economic implications of telehealth as initial visit modality for pediatric hemangioma patients, the cost-effectiveness of risk assessing asymptomatic patients with ventricular pre-excitation, racial disparities in access to prescription medications among American cancer patients, and productivity growth in American oncology.

His research has been published in Pediatrics and the Journal of Clinical Oncology and been presented at major conferences and institutions, including the American Academy of Pediatrics, the American Society of Clinical Oncology (ASCO) Annual Meeting, the ASCO Quality Care Symposium, and the Federal Reserve Bank of Cleveland. Additionally, his translational research on cancer stem cell proliferation and lysosomal membrane permeability in glioblastoma, conducted at the Cleveland Clinic Lerner Research Institute, was published in Cell Reports.

Beyond research, Manav regularly contributes op-eds at the intersection of medical education and the business of health care, with recent articles appearing in the Cincinnati Enquirer and MedPage Today.

He earned his BA in Economics with Honors and a Minor in Chemistry from Case Western Reserve University in 2022, where he was inducted into the Phi Beta Kappa Society.